Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · IEX Real-Time Price · USD
1.970
+0.030 (1.55%)
Apr 25, 2024, 11:08 AM EDT - Market open
Can-Fite BioPharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Can-Fite BioPharma stock has a target of 18, which predicts an increase of 813.71% from the current stock price of 1.97.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 24, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for CANF is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $18 | Strong Buy | Maintains | $34 → $18 | +813.71% | Oct 24, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +1,625.89% | Jun 2, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +1,625.89% | Mar 13, 2023 |
| Aegis Capital | Aegis Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jun 24, 2021 |
Financial Forecast
Revenue This Year
14.81M
from 743.00K
Increased by 1,893.41%
Revenue Next Year
10.12M
from 14.81M
Decreased by -31.67%
EPS This Year
-4.11
from -3.00
EPS Next Year
-3.85
from -4.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 42.6M | 17.7M | 41.0M |
| Avg | 14.8M | 10.1M | 21.4M |
| Low | n/a | 2.9M | 2.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5,640.1% | 19.8% | 304.9% |
| Avg | 1,893.4% | -31.7% | 111.5% |
| Low | - | -80.5% | -71.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.07 | -1.15 | -0.20 |
| Avg | -4.11 | -3.85 | -3.85 |
| Low | -5.95 | -6.31 | -7.22 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.